Table 1. Study patients.
Participant | Age | Sex | CD3CD4 count (%) | CD3CD8 count (%) | CD4/CD8 ratio | Viral load (copies/ml) | Prior Rx |
1 | 42 | M | 203 (16) | 817 (64) | 0.25 | 13,510 | No |
2 | 21 | M | 247 (17) | 995 (69) | 0.25 | 7,953 | No |
3 | 39 | M | 271 (18) | 967 (65) | 0.28 | 105,425 | Yes |
4 | 30 | M | 474 (28) | 932 (54) | 0.51 | 22,051 | No |
5 | 44 | M | 344 (22) | 923 (59) | 0.37 | 500,000 | No |
6 | 56 | M | 390 (24) | 868 (53) | 0.45 | 75,216 | No |
7 | 24 | M | 272 (41) | 246 (37) | 1.1 | 61,517 | No |
8 | 52 | M | 359 (21) | 1091 (64) | 0.3 | 484 | No |
9 | 43 | M | 530 (33) | 850 (53) | 0.6 | 27,158 | No |
10 | 43 | M | 573 (16) | 2411 (66) | 0.2 | 109,771 | Yes |
11 | 41 | M | 248 (13) | 1376 (73) | 0.2 | 111,174 | No |
Average | 39 | 355 (23) | 1043 (60) | 0.41 | 94,023 |